Saturday, March 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

Another MERS Case in U.S., Healthcare Workers Possibly Infected

by Global Biodefense Staff
May 13, 2014
MERS-CoV Coronavirus

On May 11, 2014, a second U.S. imported case of Middle East Respiratory Syndrome (MERS) was confirmed in a traveler who came to the U.S. from Saudi Arabia. The patient is currently hospitalized and doing well.

According to reports from Reuters, two health workers at the Dr. P. Phillips Hospital in Orlando, Florida who were exposed to the patient have now begun showing symptoms, and one of the two healthcare workers has been hospitalized. The second is in isolation at home, resting.

MERS Coronavirus Case at Dr. P. Phillips Hospital

Officials at the hospital say the workers were exposed to the patient in the emergency department prior to isolation of the man for suspected MERS.

“We are taking every precaution, but we believe the risk of transmission from this patient is very low since his symptoms were mild and he was not coughing when he arrived at the hospital,” stated Antonio Crespo, MD, infectious disease specialist at Dr. Phillips Hospital in Orlando, via a press release from the Florida Department of Health (FDH).

CDC and other public health partners continue to investigate and respond to the changing situation to prevent the spread of MERS-CoV in the U.S. These two cases of MERS imported to the U.S. represent a very low risk to the general public in this country.

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a virus that is new to humans and was first reported in Saudi Arabia in 2012. So far, including this U.S. importation, there have been 538 confirmed cases of MERS in 14 countries. Most of these people developed severe acute respiratory illness, with fever, cough, and shortness of breath; 145 people have died.

Tags: CoronavirusEmerging ThreatsMERS-CoV

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks
Pathogens

NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks

December 7, 2022
Bat Virus Receptor Studies Vital to Predict Spillover Risk
Pathogens

Bat Virus Receptor Studies Vital to Predict Spillover Risk

December 7, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC